Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Nicotinamide adenine dinucleotide supplementation drives gut microbiota variation in Alzheimer’s mouse model

Alzheimer’s disease (AD) is the most common neurodegenerative disease. Growing evidence suggests an important role for gut dysbiosis and gut microbiota-host interactions in aging and neurodegeneration. Our previous works have demonstrated that supplementation with the nicotinamide adenine dinucleoti...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Xixia Chu, Yujun Hou, Qiong Meng, Deborah L. Croteau, Yong Wei, Supriyo De, Kevin G. Becker, Vilhelm A. Bohr
פורמט: Article
שפה:English
יצא לאור: Frontiers Media S.A. 2022-09-01
סדרה:Frontiers in Aging Neuroscience
נושאים:
Alzheimer’s disease
nicotinamide riboside
gut microbiome
APP/PS1 transgenic mice
neuroinflammation
aging
גישה מקוונת:https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

אינטרנט

https://www.frontiersin.org/articles/10.3389/fnagi.2022.993615/full

פריטים דומים